articleThe LancetAug 31, 2010Closed access

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Uppsala University · Hamilton Health Sciences · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,009
total citations
FWCI
83.51
Percentile
100%
References
22
Citations per year

Authors

14

Topics & keywords

Keywords
  • Warfarin
  • Dabigatran
  • Medicine
  • Atrial fibrillation
  • Quartile
  • Stroke (engine)
  • Internal medicine
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding